Andrew H Galligan
CIK 1417976 · Chief Financial Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.40M
Companies
3
Total Filings
55
Lifetime Open-Market Net
-$16.57M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OOMA | Director | 250,824 | $17.55 | $4.40M | -$940.2K | 17 | 2026-06-08 |
| Arcellx, Inc. (ACLX) Delisted | Director | 0 | $115.07 | $0 | $0 | 3 | 2026-04-28 |
| NEVRO CORP (NVRO) Delisted | Chief Financial Officer | 59,179 | $5.84 | $345.6K | -$15.63M | 31 | 2020-06-08 |
Recent Filings · Page 6 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-11-07 | NEVRO CORP (NVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-08-08 | — | Grant (A) | +6,500 | $0 | |
| 2012-09-24 | — | Grant (A) | — | $0 | |
| 2011-08-12 | — | Grant (A) | — | $0 | |
| 2010-11-04 | — | Grant (A) | — | $0 |
Showing 51–55 of 55
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.